ABSI Earnings Preview: Options Price a ±17.6% Move
· The NYC Memo · ABSI reports 2026-11-11
Absci Corporation reports November 11, 2026. The November 20, 2026 straddle implies ±17.55% against a 7.45% average reaction, with dealers long gamma and max pain at $6.
Live updates
Nov 11 — Ahead of November 11, 2026 earnings, ABSI fell from $10.80 to $9.97 as the options-implied move narrowed from ±24.63% to ±17.55% and at-the-money implied volatility dropped from 163.8% to 108.7%, indicating reduced expectations for post-earnings price volatility.
Nov 10 — Ahead of its November 11, 2026 earnings, ABSI rose from $10.17 to $10.80 as at-the-money implied volatility climbed from 151.2% to 163.8%, widening the implied move from ±23.11% to ±24.63% and signaling expectations for sharper post-earnings price swings.
Absci Corporation reports on November 11, 2026, with spot trading at $9.97. Shares sit -20.5% from the peak after gaining +3.1% over the past month. For the November 20, 2026 expiry, the market prices the straddle at $1.75, implying a move of 17.55% and an implied range of $8.22 to $11.72 with atm iv at 108.7%. That pricing exceeds the average realised reaction of 7.45% across 7 prints counted, which produced 3 higher and 4 lower reactions.
Dealers hold a long gamma lean, while put_call_oi stands at 0.20 and max pain is $6. That dealer positioning obligates desks to buy dips and sell rallies, dampening realized volatility into the print.
What the market will be watching
The options desk will focus on partnership momentum and platform adoption when Absci Corporation reports results. Traders want to see active biopharma partner additions to validate commercial demand for the generative artificial intelligence drug creation platform. Research spending and operating cost pressures will determine the margin trajectory and cash runway discipline. Updates to full-year guidance will steer sentiment, particularly around milestone payments and signed collaboration programs. Any concrete advances across internal drug candidates or partnered pipeline programs will drive the immediate post-earnings move.
What the options market is pricing
| Measure | Level |
|---|---|
| November 11, 2026 | |
| Expiry used | November 20, 2026 (9 days out) |
| Spot | $9.97 |
| ATM straddle | $1.75 |
| Implied move | ±17.55% ($8.22 to $11.72) |
| ATM implied vol | 108.7% |
| Put/call open interest | 0.20 |
| Max pain | $6 |
| Net dealer gamma | +$0.15mn per 1% move, LONG GAMMA |
| Heaviest call strike above spot | $11 (2,787 contracts) |
| Heaviest put strike below spot | $8 (1,120 contracts) |
Dealers sit long gamma into the print, which means their hedging leans against the move and tends to compress ABSI between catalysts. That damping disappears the moment the number crosses the tape.
How the stock has reacted before
| Report | Next-day move |
|---|---|
| Q2 2026, Aug 11 | +0.96% |
| Q1 2026, May 7 | +2.61% |
| Q4 2025, Mar 24 | -2.99% |
| Q3 2025, Nov 12 | -22.35% |
| Q2 2025, Aug 12 | +5.05% |
| Q4 2024, Mar 18 | -3.25% |
| Q3 2024, Nov 12 | -14.95% |
Across the last 7 prints the average absolute reaction is 7.45%, with 3 higher and 4 lower. The best was +5.05% and the worst -22.35%. Options are asking ±17.55%, which is 10.10 points richer than the realised average, the premium seller's case.
Where the stock is trading
| Measure | Level |
|---|---|
| Spot | $9.97 |
| 52-week range | $2.24 to $12.55 |
| Position in that range | 75% |
| From the 52-week high | -20.5% |
| From the 52-week low | +345.1% |
| Past week | -0.3% |
| Past month | +3.1% |
| Past three months | +5.0% |
| 50-day average | $9.63 |
| 200-day average | $6.74 |
How the options market is pricing it
The November 20, 2026 straddle marks $8.22 to $11.72 as the range the options market is paying for into the print, with ATM implied vol at 109% set to drain the morning after. A reaction inside that band hands the edge to premium sellers; a break outside it rewards premium buyers. Historically ABSI has moved 7.45% on earnings against the ±17.55% now implied, so the market is pricing this print richer than the recent average. Which side of that trade is right depends on the number, the guidance and where positioning unwinds.
Read the mechanics behind the crush in our earnings volatility guide, and pull the live memo for ABSI before the print.
Data as of November 11, 2026 from the live option chain, exchange price history and SEC-dated earnings reactions. This is research, not investment advice.
Related: ABSI options memo